Welcome to our dedicated page for Bruker Corporation news (Ticker: $BRKR), a resource for investors and traders seeking the latest updates and insights on Bruker Corporation stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Bruker Corporation's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Bruker Corporation's position in the market.
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) has announced the acquisition of Nanophoton Corporation, a pioneer in advanced research Raman microscopy systems. Nanophoton's acquisition fills a gap in Bruker's molecular microscopy portfolio, offering fast, flexible, and sensitive Raman microscopy systems worldwide for research and development in various industries. The acquisition is expected to enhance Bruker's molecular microscopy portfolio, offering exceptional speed, sensitivity, and spatial resolution. Nanophoton's CEO founder expressed excitement about the partnership with Bruker, while the President of Bruker Optics division welcomed the Nanophoton team and acknowledged their expertise in innovating Raman microscopy. Financial terms of the acquisition were not disclosed, but in 2023, Nanophoton Corporation had revenues of approximately $5 million and was near break-even.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.3%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) has acquired Spectral Instruments Imaging LLC, a leader in preclinical in-vivo optical imaging systems. The acquisition fills a gap in Bruker's technology and product portfolio, broadening its range of preclinical solutions for disease research. SII generated revenues of over $10 million in 2023 and was profitable.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.3%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) will report Q4 and fiscal year 2023 financial results on February 13, 2024. A conference call and webcast will be held to discuss the results and current business trends. Investors can listen to the webcast and earnings call via the company's website or telephone. Pre-registration for the call is available to expedite entry.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.88%
Tags
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) introduced the ground-breaking, new ‘Triceratops’ SPR #64 Surface Plasmon Resonance (SPR) instrument at the SLAS2024 International Conference and Exhibition. The SPR #64 system is designed to accelerate drug discovery with increased throughput, leading sensitivity, and data quality. The system combines highest sensitivity detection with a novel microfluidics concept and facilitates the simultaneous reading of 64 sensor spots, extending SPR capabilities beyond previous limits. Automation features and integrated software make it a milestone in convenient SPR-based biopharma research.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.49%
Tags
-
Rhea-AI Summary
Bruker Corporation (Nasdaq: BRKR) has announced the acquisition of Chemspeed Technologies AG, a Swiss provider of automated laboratory R&D and QC workflow solutions. The acquisition accelerates Bruker’s lab automation and digitalization drive, complementing its vendor-agnostic platform SciY™. Chemspeed generated revenues greater than $50 million in 2023 and was profitable. The transaction is expected to close in the first half of 2024, subject to regulatory reviews.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.18%
Tags
-
Rhea-AI Summary
Biognosys, a leader in next-generation proteomics solutions, opens a new CRO facility in Massachusetts to provide high-throughput proteome profiling services for US biopharma customers. The facility will focus on TrueDiscovery® data-independent acquisition (DIA) discovery proteomics services, powered by the Bruker timsTOF mass spectrometry platform. The expansion aims to bring cutting-edge proteomics closer to US customers, enabling them to leverage the potential of proteomics for therapeutic discoveries and drug development.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-1.33%
Tags
Rhea-AI Summary
Bruker (BRKR) acquires Canadian company Tornado Spectral Systems Inc., specializing in process Raman instruments for pharma and biotech quality control. Tornado's patented technologies and product line will enhance Bruker's biopharma PAT portfolio. Financial details were not disclosed.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) to participate in 42nd annual J.P. Morgan Healthcare Conference, with top executives presenting on January 8th, 2024. Live webcast and replay available on the Company's Investor Relations website.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.69%
Tags
-
Rhea-AI Summary
Bruker Corporation (BRKR) Acquires Nion, a Leader in High-End STEM Technology for Materials Science Research
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.27%
Tags
Rhea-AI Summary
Bruker Corporation (BRKR) installs a 1.2 Gigahertz (GHz) NMR system at The Ohio State University, enabling advanced life science and materials research. The system will be used for high-resolution liquid and solid-state NMR experiments to study advanced materials and biological molecules, with the goal of advancing the understanding of the underlying mechanisms of diseases such as cancer, cardiovascular disease, viral infections, or Alzheimer’s disease.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.52%
Tags
Bruker Corporation
Nasdaq:BRKR
BRKR Rankings
BRKR Stock Data
11.15B
89.37M
34.66%
81.89%
2.41%
Analytical Laboratory Instrument Manufacturing
Manufacturing
United States of America
BILLERICA
About BRKR
right from the beginning, which is now more than fifty years ago, bruker has been driven by a single idea: to provide the best technological solution for each analytical task. today, worldwide, more than 6,500 employees in over 90 locations on all continents are focusing their efforts on this permanent challenge. bruker systems cover a broad spectrum of applications in all fields of research and development and are used in all industrial production processes for the purpose of ensuring quality and process reliability. bruker continues to build upon its extensive range of products and solutions, expand its broad base of installed systems and maintain a strong reputation amongst its customers. as one of the world's leading analytical instrumentation companies, bruker remains focused on developing state-of-the-art technologies and innovative solutions for today’s ever complex analytical questions. bruker - innovation with integrity. bruker corporation company pages bruker axs: https://www